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bjectives This study sought to systematically compare the effectiveness of percutaneous coronary
ntervention and coronary artery bypass surgery in patients with single-vessel disease of the proxi-
al left anterior descending (LAD) coronary artery.
ackground It is uncertain whether percutaneous coronary interventions (PCI) or coronary artery
ypass grafting (CABG) surgery provides better clinical outcomes among patients with single-vessel
isease of the proximal LAD.
ethods We searched relevant databases (MEDLINE, EMBASE, and Cochrane from 1966 to 2006) to
dentify randomized controlled trials that compared outcomes for patients with single-vessel proxi-
al LAD assigned to either PCI or CABG.
esults We identiﬁed 9 randomized controlled trials that enrolled a total of 1,210 patients (633 re-
eived PCI and 577 received CABG). There were no differences in survival at 30 days, 1 year, or 5
ears, nor were there differences in the rates of procedural strokes or myocardial infarctions,
hereas the rate of repeat revascularization was signiﬁcantly less after CABG than after PCI (at 1
ear: 7.3% vs. 19.5%; at 5 years: 7.3% vs. 33.5%). Angina relief was signiﬁcantly greater after CABG
han after PCI (at 1 year: 95.5% vs. 84.6%; at 5 years: 84.2% vs. 75.6%). Patients undergoing CABG
pent 3.2 more days in the hospital than those receiving PCI (95% conﬁdence interval: 2.3 to 4.1
ays, p  0.0001), required more transfusions, and were more likely to have arrhythmias immedi-
tely post-procedure.
onclusions In patients with single-vessel, proximal LAD disease, survival was similar in CABG-
ssigned and PCI-assigned patients; CABG was signiﬁcantly more effective in relieving angina and
ed to fewer repeat revascularizations. (J Am Coll Cardiol Intv 2008;1:483–91) © 2008 by the
merican College of Cardiology Foundation
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484ercutaneous coronary interventions (PCI) (with or without
tents) and coronary artery bypass graft (CABG) surgery are
he alternative approaches to revascularization for patients
ith isolated stenosis of the proximal left anterior descend-
ng (LAD) (1,2). Some studies have reported fewer repeat
evascularization procedures and more freedom from angina
mong patients with isolated LAD stenosis who have
eceived CABG rather than PCI (3,4). However, proce-
ural morbidity such as stroke is reported to be higher
mong CABG recipients (5). Some investigators argue that
dvances in CABG procedures, such as the use of minimally
nvasive direct coronary artery bypass (MIDCAB) (which
as developed initially to treat proximal LAD stenosis),
ay decrease procedural morbidity with similar graft pa-
ency rates compared with traditional CABG (6). However,
thers suggest that the technical challenge of MIDCAB
ay lead to poor or improper anastomosis, acute graft
ailure, and need for full sternotomy (5,7). In light of these
onflicting views, there is no clear consensus as to the best
coronary revascularization pro-
cedure for patients with single-
vessel proximal LAD lesions.
See page 492
Prior systematic reviews of
trials comparing CABG and
PCI have not specifically re-
ported outcomes for patients
with single-vessel disease of the
proximal LAD (8–13). Addi-
tionally, since the publication of
these reviews, new trial data
from patients with proximal
LAD disease have become avail-
ble (5,14–19). We therefore reviewed current data on
utcomes after random assignment to PCI or CABG
mong patients with single-vessel disease of the proximal
AD.
ethods
earch strategy. We identified randomized controlled trials
RCTs) that compared outcomes for patients with single-
essel proximal LAD disease assigned to either PCI or
ABG. We performed individualized searches of relevant
atabases (MEDLINE, EMBASE, and Cochrane from
966 to 2006) with terms such as angioplasty, coronary, and
oronary artery bypass surgery (complete search strategies are
vailable elsewhere [12]). We also manually searched refer-
nce lists of included articles and the bibliographies of
xpert advisors. We did not limit searches to the English
bbreviations
nd Acronyms
ABG  coronary artery
ypass grafting
I  confidence interval
AD  left anterior
escending
IDCAB  minimally
nvasive direct coronary
rtery bypass
CI  percutaneous
oronary interventions
CT  randomized
ontrolled trialanguage. rtudy selection. We searched for RCTs that compared PCI
nd CABG in patients with angiographically proven single-
essel disease of the proximal LAD. Trials were included
ithout limitation to subject population, year, or type of
urgical or percutaneous intervention. We excluded RCTs
omparing only 2 or more PCI technologies or 2 or more
ABG technologies. The trials included a variety of PCI
echnologies (i.e., balloon angioplasty, with or without
tents) and a variety of surgical procedures (i.e., traditional
n-pump and off-pump bypass procedures, and minimally
nvasive procedures).
ata extraction. We abstracted the following data from the
ncluded trials: study design; setting; population character-
stics; detailed information about the PCI and CABG
nterventions performed; numbers of patients screened,
ligible, enrolled, and lost to follow-up; method of outcome
scertainment; and results for each outcome. The outcomes
f interest included both procedural outcomes (e.g., proce-
ural stroke, length of stay) and long-term outcomes (e.g.,
urvival, angina relief, repeat revascularization, quality of
ife). Two authors independently reviewed the title, abstract,
nd full text of each included study. We resolved abstraction
onflicts by re-review and discussion.
uality assessment of individual studies. We used pre-
efined criteria to assess the quality of included trials as
ood, fair, or poor (20–22). These quality criteria included
he method of randomization, the use of intention-to-treat
nalysis, the report of dropout rates, and the extent to which
alid outcomes were described.
ata synthesis. We computed summary risk differences and
ummary odds ratios for each outcome of interest using
andom effects models. Because the results were consistent
etween these methods, we present summary risk differ-
nces because several of the outcomes of interest (e.g.,
rocedural mortality) were rare events and the risk differ-
nce is a more stable outcome metric than odds ratios under
hese circumstances (23,24).
We assessed heterogeneity for summary effects by calcu-
ating the chi-square and I2 statistics (25) and considered I2
tatistics in excess of 50% to indicate heterogeneity. We
ought evidence of publication bias by evaluating the asso-
iation between the sample size of a study and the likelihood
f that study reporting statistically significant outcomes by
isual inspection of funnel plots. We also performed sensi-
ivity analyses by evaluating the effects of individual studies
n reported summary effects by removing each study
ndividually.
esults
ur searches for RCTs comparing the efficacy of PCI and
ABG yielded 1,695 potentially relevant articles, of which
04 articles merited full-text review. A total of 17 articles
eporting on 9 RCTs met our inclusion criteria (Fig. 1).
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485escription of the RCTs. The 9 RCTs of patients with
ingle-vessel disease of the proximal LAD artery enrolled
,210 patients (633 received PCI and 577 received CABG)
Table 1). Seven of the 9 trials were single-center studies,
nd most were conducted in Europe. The early studies
patient entry 1987 to 1993) used balloon angioplasty as the
CI technique (1,3,4,26), and the recent studies (1994 to
002) used stents as the PCI technique (5,14–19,27–32).
he early studies used traditional CABG, whereas the more
ecent studies used MIDCAB and off-pump techniques
5,15–18). Although there were some differences in the
nclusion criteria of the RCTs, all 9 trials limited entry to
atients with single-vessel disease of the proximal LAD.
The mean age of trial participants ranged from 53 to 63
ears. Roughly 20% had diabetes, and more than half had
ypertension and/or hyperlipidemia (Table 2). The propor-
ion of women included in the trials ranged from 17% to
6%. The prevalence of heart failure was low, and left
entricular function was generally well preserved.
uality of the randomized controlled trials. The quality of
ost trials was high, and 7 trials received a grade of good
ecause they clearly explained their randomization methods,
heir dropout rates were low, and they performed intention-
o-treat analyses. Because it was not clear that there was
oncealment of allocation or intention-to-treat and some data
ere obtained via a retrospective review of charts, the Seoul-
im (18) trial received a fair grade. We assigned a grade of
oor to the Seoul-Hong (17) trial because, in addition to the
act that it was a small trial with very short follow-up (6
onths), it may not have been truly randomized, as evidenced
citations
searches results in 1695 potentially relevant
, selectedEmbase, Cochrane,MEDLINE
1491 
Not 
Not 
Othe
Stage 2: Full text review and abstraction by 
two independent investigators resulted in 17 
articles representing nine studies. 
Oth
Did
Not
Not
187 E
204 citations requiring full text review
by two independent investigators resulted in
Stage 1: Review of title and abstracts
Figure 1. Search Results
The number of citations retrieved from the literature searches and the rationa
graft; CAD  coronary artery disease; PCI  percutaneous coronary interventioy the imbalance between the number of patients assigned to tCI (119) and to CABG (70). Neither the investigators nor
he journal editor responded to requests for clarification of
he method of randomization. We performed sensitivity
nalyses by removing the Seoul-Hong trial from our main
utcome analysis, without any substantial change in our
esults. The Seoul-Hong trial is the only included trial that
ompared PCI using drug-eluting stents (17).
hort-term/procedural outcomes. SURVIVAL. We defined
hort-term/procedural complications as those occurring
ithin the first 30 days of the revascularization procedure.
rocedural survival was above 99% for both procedures
Table 3). When data from all trials were combined, the
bsolute difference in procedural survival did not differ
ignificantly between procedures (risk difference: 0.3%, 95%
onfidence interval [CI]: 0.9% to 1.4%) (Fig. 2). We
erformed separate analyses for the patients who received
IDCAB and those that received traditional CABG, and
ound no differences in procedural survival between PCI and
ABG—regardless of the specific surgical technique per-
ormed. Similarly, we found no difference in comparative
rocedural survival between MIDCAB or off-pump trials
ompared with PCI at 1 month. There was no substantial
vidence for statistical heterogeneity or publication bias.
THER OUTCOMES. Procedural strokes were also relatively
are: about 0.5% for both procedures. There was no differ-
nce in the absolute rate of procedural stroke (reported by 6
rials) between PCI and CABG (absolute risk difference:
.2%, 95% CI: 1.2% to 1.6%).
In all 5 studies that reported length of stay (Table 4),
atients undergoing CABG consistently spent more time in
ions
parison of PCI vs. CABG for CAD: 1286
T: 190
clude just single vessel disease:  96
parison of the efficacy of PCI vs. CABG for CAD: 13 
T: 67
ons
inclusion and exclusion for each citation. CABG  coronary artery bypass
T  randomized controlled trial.Exclus
a com
an RC
r: 15
er: 11
 not in
 a com
 an RC
xclusi
le forhe hospital (range: 4.5 to 10.1 days) than those receiving
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486CI (range: 2.3 to 6.1 days) (absolute difference  3.2 days,
5% CI: 2.3 to 4.1 days, p  0.0001).
The summary rate of procedural myocardial infarction
as reported by all studies and did not differ significantly
etween PCI and CABG: absolute risk difference 
0.8%; 95% CI: 2.6% to 0.9%. It is important to note
hat the definition of myocardial infarction varied among
tudies, and post-procedure serial monitoring of electrocar-
iograms and serum biomarker levels was not routine, so
hat ascertainment of procedural myocardial infarctions may
ot have been uniform or complete.
The AMIST (Angioplasty versus Minimally Invasive
urgery Trial) (14) and SIMA (Stenting versus Internal
ammary Artery) (19) trials reported differences in rates of
rocedural arrhythmias, and both found an increased risk of
vents with CABG than with PCI. None of the patients in the
CI arms of either trial experienced any arrhythmias, whereas
9% of CABG recipients experienced atrial fibrillation and
pproximately 2% had a ventricular arrhythmia.
In the 3 studies that reported procedural bleeding,
Table 1. General Description of the Randomized Controlled Trials
Trial
(Associated
References) Region(s)
Number
of Sites
Years of
Enrollment
AMIST (14) UK 6 1999–2001
Groningen (15,27–29) Holland 1 1997–1999
Lausanne (3,4) Europe 1 1989–1993
Leipzig (5,30,31) Europe 1 1997–2001
MASS (1,26) South America 1 1988–1991
Poland (16,32) Europe 1 2000–2001
Seoul-Hong (17) Asia 1 2003
Seoul-Kim (18) Asia 1 2000–2001
SIMA (19) Europe 6 1994–1998
BMS bare-metal stent; CABG coronary artery bypass graft; DES drug-eluting stent; LAD le
coronary artery bypass; NS not specified; PCI percutaneous coronary intervention.ore CABG-assigned patients required transfusions than [id PCI-assigned patients (Table 5); however, the total
umber of patients requiring transfusion was small, and the
ifference in procedural bleeding was not significant.
ong-term outcomes. SURVIVAL. Overall survival among
ABG-assigned patients was 97.9% at 1 year and 92.8% at
years. Overall survival among PCI-assigned patients was
9.7% at 1 year and 90.6% at 5 years. The combined data
rom all trials showed no statistically significant difference in
verall survival in either the first or fifth year post-procedure
or PCI and CABG. There was no substantial evidence for
tatistical heterogeneity or publication bias.
Survival did not differ between PCI and CABG for either
alloon angioplasty or stents. At 1 year, survival in studies
sing balloon angioplasty was 1% greater for CABG recip-
ents (95% CI: 5% to 2%), but the difference was not
tatistically significant. In trials that used stents, the risk
ifference (0.1% favoring PCI) also was not statistically
ignificant (95% CI: 4% to 4%).
In addition to reporting overall mortality, 3 studies
eported cardiovascular mortality at 5 years (the MASS
umber of Subjects
Randomized/
Receiving
ssigned Therapy
PCI Intervention Surgical InterventionCI Surgery
/48 50/46 Stents available,
not required
LIMA to LAD
/51 51/48 BMS LIMA using small left anterior
thoracotomy, beating
heart with mechanical
stabilizer
/68 66/59 Balloon
angioplasty
Median sternotomy, LIMA,
hypothermia
/110 110/110 BMS MIDCAB: limited left
anterolateral thoracotomy,
LIMA with mechanical
stabilizers, beating heart
/NS 70/NS Balloon
angioplasty
LIMA, mild hypothermia,
extracorporeal circulation
/50 50/50 BMS MIDCAB: LIMA under
mechanical stabilization
on beating heart through
anterior thoracotomy
/NS 70/NS DES Off-pump LIMA with
mechanical stabilization
on beating heart,
anterolateral thoracotomy
/49 50/49 BMS MIDCAB: LIMA with
mechanical stabilization
on beating heart through
mini-sternotomy
/62 60/54 BMS MIDCAB, cardioplegia and
hypothermia
rior descending artery; LIMA left internal mammary artery; MIDCABminimally invasive directN
A
P
50
51
68
110
72
50
119
50
63
ft anteMedicine, Angioplasty or Surgery Study] [1], Leipzig [5],
L
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487ausanne [3]), but none reported significant differences
etween the procedures.
THER OUTCOMES. Angina relief was significantly greater
year after CABG (absolute rate: 95.5%) than 1 year after
Table 2. Subject Baseline Demographics and Clinical Characteristics
Trial Intervention
Age
(Mean)
Women,
%
AMIST (14) PCI Median 54.5 14
CABG Median 58.8 30
Groningen (15) PCI 61.0 25
CABG 60.0 22
Lausanne (3) PCI 57.0 20
CABG 54.0 20
Leipzig (5) PCI 62.5 28
CABG 61.6 23
MASS-I (1) PCI 54.0 19
CABG 58.0 17
Poland (16) PCI 53.3 16
CABG 54.1 18
Seoul-Hong (17) PCI 60.5 36
CABG 61.4 36
Seoul-Kim (18) PCI 61 40
CABG 63 30
SIMA (19) PCI 59.0 24
CABG 60.0 17
HTN hypertension; LVEF left ventricular ejection fraction; NR not reported; other abbreviatio
Table 3. Procedural Outcomes
Trial Intervention
Procedural
All-Cause Mortality, %* N
AMIST (14) PCI 0
CABG 0
Groningen (15) PCI 0
CABG 3.9
Lausanne (3) PCI 0
CABG 0
Leipzig (5) PCI 0
CABG 1.8
MASS-I (1) PCI 0
CABG 0
Poland (16) PCI 0
CABG 0
Seoul-Hong (17) PCI 1.7
CABG 1.4
Seoul-Kim (18) PCI 0
CABG 0
SIMA (19) PCI 1.6
CABG 0
*Percentage based on the number of subjects randomized at the start of the study.MImyocardial infarction; other abbreviations as in Tables 1 and 2.CI (absolute rate: 84.6%) in the 4 trials that reported this
utcome (risk difference  7.9%, 95% CI: 1.9% to 14.0%,
 0.01). Similarly, angina relief remained significantly
reater 5 years after CABG (absolute rate: 84.2%) than 5
betes,
%
HTN,
%
Hyperlipidemia,
%
Unstable
Angina, %
LVEF
(Mean)
NR NR NR 18 NR
NR NR NR 20 NR
18 NR 45 NR NR
8 NR 41 NR NR
12 46 50 12 NR
12 41 52 8 NR
34 72 70 NR 63
25 71 73 NR 63
15 34 NR NR 77
18 30 NR NR 74
8 52 78 10 NR
6 56 76 8 NR
37 50 55 50 53
49 56 51 43 52
20 55 60 65 51
15 55 70 55 49
11 44 60 48 67
13 47 53 48 67
Table 1.
edural
l MI, %*
Other Short-Term Complications*
Stroke,
%
PCI
Reintervention, %
Surgical
Reintervention, %
NR NR NR
NR NR 2.0
.8 2.0 NR 0.0
.0 0.0 NR 2.0
.9 NR NR NR
.5 NR NR NR
.8 0.0 1.8 NR
.6 0.9 NR 2.7
.8 0.0 NR NR
.4 0.0 NR NR
.0 NR 6.0 NR
NR 0.0 NR
.3 0.0 1.7 NR
.9 1.4 1.4 NR
NR 2.0 2.0
NR 2.0 0.0
.8 1.6 NR NR
.3 NR NR NRDiaProc
onfata
0
0
9
2
2
1
1
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2
1
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488ears after PCI (absolute rate: 75.6%) in the 2 trials that
eported this outcome (risk difference  8.8%, 95% CI:
.8% to 15.8%).
The rate of repeat revascularization was significantly
reater after PCI (19.5%) than after CABG (4%) in the
trials that reported this at 1 year (risk difference 
4.4%, 95% CI: 6.1% to 22.6%, p  0.001,). The 3
rials that reported revascularization rates at 5 years also
eported reduced revascularization after CABG (sum-
ary rates 33.5% for PCI vs. 7.3% for CABG; p 
.0001, risk difference  26.7%, 95% CI: 20.1% to
3.3%) (Fig. 3).
Data on quality of life were collected by only 2 trials with
maximum follow-up of 15 months (Table 6). The mea-
ures chosen included the SF-36, Seattle Angina Question-
Statistics for each study Surv ival / Total
Risk Lower Upper
difference limit limit p-Value PCI CABG
0.000 -0.029 0.029 1.000 68 / 68 66 / 66
0.000 -0.027 0.027 1.000 72 / 72 70 / 70
0.000 -0.020 0.020 1.000 140 / 140 136 / 136
0.000 -0.038 0.038 1.000 50 / 50 50 / 50
0.039 -0.025 0.103 0.229 51 / 51 49 / 51
0.018 -0.012 0.048 0.239 110 / 110 108 / 110
0.000 -0.038 0.038 1.000 50 / 50 50 / 50
-0.003 -0.039 0.034 0.891 117 / 119 69 / 70
0.000 -0.038 0.038 1.000 50 / 50 50 / 50
-0.016 -0.059 0.028 0.474 62 / 63 60 / 60
0.004 -0.011 0.019 0.585 490 / 493 436 / 441
0.003 -0.009 0.014 0.661 630 / 633 572 / 577
Study name
Lausanne
MASS 
AMIST
Groningen 
Leipzig 
Poland 
Seoul-Hong
Seoul-Kim
SIMA 
Heterogeneity Statistics:
Balloon trials: Q=0.0, p=1.0; I2=0.0.
Stent trials:  Q=3.1, p=0.8; I2=0.0.
All SVD trials:  Q=3.2, p=0.9; I2=0.0.
Summary for All SVD Trials 
Summary for Stent Trials
Summary for Balloon Trials 
Figure 2. Procedural Survival in Balloon Angioplasty or Stent Trials Versus
A comparison of absolute differences in procedural survival in the PCI and CAB
in Figure 1.
Table 4. Length of Hospital Stays
Trial Intervention
Length of Stay
(Mean Number
of Days  SD) p Value
AMIST (14) PCI Median  2 NR
CABG Median  6
Groningen (15) PCI 3 NR
CABG 7
Seoul-Hong (17) PCI 5.8 2.1 0.001
CABG 8.9 2.6
Seoul-Kim (18) PCI 6.1 3.2 0.0008
CABG 10.1 3.1
Poland (16) PCI 2.3 0.3 0.001
CABG 4.5 1.3Abbreviations as in Tables 1 and 2.aire, and the EuroQol. No significant differences were
eported between PCI and CABG recipients.
iscussion
his meta-analysis of randomized controlled trials compar-
ng PCI and CABG in patients with single-vessel disease of
he proximal LAD who were eligible for both procedures
ad 3 key findings. First, there was no difference in survival
t any time point between PCI and CABG recipients.
econd, within the first 30 days of the procedure, there was
o difference in the rates of stroke or myocardial infarction,
ut CABG patients were more likely to require transfusions,
ave arrhythmias, and require longer hospital stays. Third,
here was a much lower rate of repeat revascularization and
igher rate angina relief in patients undergoing CABG than
CI.
The finding of equivalent survival between CABG and
CI in patients with isolated LAD disease parallels other
Risk difference and 95%  CI
-0.05 -0.03 0.00 0.03 0.05
Favors CABG Favors PCI
ups in each of the trials. SVD  single-vessel disease; other abbreviations as
Table 5. Blood Transfusion Rates Reported
Trial Intervention
Number of Patients
Requiring Blood
Transfusion (%) p Value
AMIST (14) PCI 0/49 (0) NR
CABG 1/49 (2)
Seoul-Kim (18) PCI 0/50 (0) 0.5
CABG 1/50 (2)
SIMA (19) PCI 2/121 (3) 0.01
CABG 5/121 (9)CABG
G groAbbreviations as in Tables 1 and 2.
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489Study name
Poland
Seoul-Kim
Study name
Lausanne
Leipzig
MASS
Statistics for each study Risk difference and 95% CI
Risk Lower Upper
difference limit limit p-Value PCI CABG
-0.185 -0.322 -0.048 0.008 37 / 49 47 / 50
-0.120 -0.224 -0.016 0.023 43 / 50 49 / 50
-0.144 -0.226 -0.061 0.001 80 / 9996 / 100
-0.25 -0.13 0.00 0.13 0.25
Favors CABG Favors PCI
t
Statistics for each study Risk difference and 95% CI
Risk Lower Upper
difference limit limit p-Value PCI CABG
-0.290 -0.427 -0.153 0.000 40 / 65 59 / 65
-0.224 -0.332 -0.117 0.000 71 / 106 93 / 104
-0.296 -0.403 -0.188 0.000 50 / 71 69 / 69
-0.267 -0.333 -0.201 0.000 161 / 242221 / 238
-0.50 -0.25 0.00 0.25 0.50
Favors CABG Favors PCI
Heterogeneity Statistics:  Q=0.56, p=0.5; I2=0.0. 
Heterogeneity Statistics:  Q=0.99, p=0.6; I2=0.0. 
Figure 3. Freedom From Repeat Revascularization at 12 and 60 MonthsA comparison of absolute differences in repeat revascularizations in the PCI and CABG groups in each of the trials. Abbreviations as in Figure 1.Table 6. Quality of Life Information
Trial Instrument Measure Time Point PCI CABG
Intervention
Favored
AMIST (14) SAQ Physical limitation 6 months 76.3 78.6 NS
Quality of life 6 months 68.1 68 NS
Physical limitation Year 1 80.4 81 NS
Quality of life Year 1 72.6 71.5 NS
SF-36 Physical Component Summary Score 6 months 37.4 38.0 NS
Mental Component Summary Score 6 months 51.1 52.4 NS
Physical Component Summary Score Year 1 37.7 39.4 NS
Mental Component Summary Score Year 1 51.4 55.0 CABG†
Euroqol Utility 6 months 0.78 0.80 NS
Health status 6 months 74.3 79.7 NS
Utility Year 1 0.77 0.82 NS
Health status Year 1 74.6 81.7 NS
SIMA (19) SF-36 9–15 months*
SAQ Physical limitation 9–15 months 86 91 NS
Quality of life 9–15 months 79 76 NS
*No summary scores were provided; however, the scores on each section are available in the text. There was no statistically significant difference between PCI and CABG scores in any domain. †p 0.05.SAQ Seattle Angina Questionnaire; SF-36Medical Outcomes Study 36-Item Short Form Health Survey; other abbreviations as in Table 1.
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490ecent analyses of patients with other types of coronary
rtery disease receiving either revascularization procedure
33). Two major clinical registries have reported long-term
urvival for patients with single-vessel disease (34,35).
hese registries clearly suggest that most patients with
ingle-vessel disease received PCI, and most patients with
ore extensive disease received CABG. In the Duke Uni-
ersity Medical Center registry overall, 2,924 patients were
reated by angioplasty and 3,890 patients underwent bypass
urgery (34). The adjusted 5-year survival in patients with
ingle-vessel, proximal LAD stenosis of 95% was 0.89 when
reated with CABG and 0.88 when treated with PCI. In the
ew York registry overall, 29,930 patients underwent an-
ioplasty and 29,646 patients underwent bypass surgery, of
hich 9,998 patients had single-vessel LAD angioplasty
nd 2,070 patients had single-vessel LAD bypass (35). The
djusted 3-year survival for patients with proximal LAD
isease was 96.6% for CABG versus 95.2% for PCI (p 
.01). Interestingly, we found no evidence that newer PCI
echnologies such as the use of bare-metal stents conferred
survival benefit over CABG. Similarly, advances in surgi-
al techniques such as the use MIDCAB or off pump did
ot result in greater survival benefit than PCI. However,
ecause there has been only 1 small trial of PCI versus
ABG used drug-eluting stents (17), further clinical trials
re needed to address the comparative efficacy of PCI and
ABG for patients with isolated LAD lesions. Recent
afety concerns about drug-coated stents emphasize the
eed for extended follow-up and trials large enough to
etect clinically meaningful differences in outcomes. Fur-
hermore, although longer follow-up will be required to
easure the impact of saphenous vein bypass graft disease
n comparative outcomes, the procedural risk of CABG in
arge registries has also declined progressively over time,
ndicating that both CABG and PCI methods continue to
volve.
Prior reviews of patients with a broad spectrum of
oronary artery disease (not just patients with single-vessel
isease) have shown that the rate of procedural stroke was
igher after CABG (1.2%) than after PCI (0.6%) (12,13).
ur finding that the rate of procedural stroke was equivalent
or PCI and CABG likely reflects the limited nature of both
oronary and cerebrovascular disease in this review.
The finding that CABG was associated with improved
ngina relief and decreased need for revascularization sup-
orts the finding of prior systematic reviews (12,13). It is
ncertain whether the greater angina relief seen was attrib-
table to more complete initial revascularization with sur-
ery or because of restenosis after PCI.
Our analysis had several key limitations. First, given the
mall number of studies available for review, our analysis
ay be underpowered to detect differences in clinical
utcomes and adverse events. Second, the generalizability of
ur results reflects the inclusion criteria of the RCTs.amely, the trials generally excluded patients over the age of
5 years, with acute myocardial infarction, or severe left
entricular systolic dysfunction, and the proportion of
omen included in the trials ranged from 17% to 36%; thus,
ur conclusions about the comparative efficacy of PCI and
ABG is limited for these patients. In addition, many
tudies excluded technically difficult lesions for PCI such as
AD bifurcation lesions, again limiting generalizability.
lso, the included trials did not report specific outcomes by
ey subgroups (e.g., by race/ethnicity, by comorbidities),
imiting our ability to evaluate the comparative efficacy of
CI and CABG by these critical subgroups. Although both
he exact location and severity of a proximal LAD stenosis
elate to prognosis, few of these trials strictly defined
roximal LAD by these criteria prospectively.
The combined comparative evidence on PCI and CABG
or isolated LAD disease suggests that because there is no
ignificant difference in mortality, other factors such as
atient preference or hospital or provider experience as well
s anatomic variables (LAD diameter, lesion length, side
ranch involvement, ostial disease, calcification, and so on)
hould weigh heavily in the treatment decision. Future
tudies should evaluate the extent to which the comparative
fficacy of PCI and CABG might be affected by other key
atient characteristics such as age, gender, and comorbidi-
ies to provide more patient-specific data to inform the
reatment decisions of patients and their clinicians.
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